About us

A research-driven company advancing pediatric retinal imaging.

BioLight Engineering LLC (BEL) develops portable, non-mydriatic ultra-widefield fundus cameras for pediatric retinal examination.

BioLight is developing a family of portable, non-mydriatic ultra-widefield fundus cameras — a dedicated handheld camera (PedCam) and a smartphone-based system (PedCam-SP) — both investigational and under active development.

Our Mission

BioLight Engineering LLC’s mission is to develop, validate, and commercialize innovative ophthalmic imaging technologies that are affordable, clinically effective, and practical for use in diverse healthcare settings. By combining advanced optical engineering with clinician-centered design, we seek to improve the early detection, diagnosis, and management of retinal diseases and help prevent avoidable vision loss.

A central focus of our mission is expanding access to retinal examinations for infants and children, particularly in communities where specialized eye care and conventional imaging systems are limited or unavailable. We are developing portable, easy-to-use, nonmydriatic ultra-widefield retinal imaging technology that can be deployed wherever care is needed, including hospitals, neonatal units, community clinics, mobile screening programs, and underserved regions.

Through close collaboration with clinicians, researchers, healthcare organizations, and community partners, BioLight Engineering aims to translate optical innovations into scalable clinical solutions that simplify retinal screening, support timely treatment decisions, and improve eye health outcomes worldwide.

Our Vision

BioLight Engineering LLC envisions a future in which advanced eye care is accessible to every community, regardless of geography, income, or healthcare infrastructure. Our goal is to transform retinal screening through affordable, clinically effective, and easy-to-use optical imaging technologies that enable earlier diagnosis, timely treatment, and long-term preservation of vision.

We are particularly committed to preventing avoidable childhood blindness. No child should lose vision because a treatable eye condition was not detected early enough or because appropriate imaging technology was unavailable. By developing portable, nonmydriatic ultra-widefield retinal cameras, BioLight Engineering seeks to streamline eye examinations and expand screening beyond specialized ophthalmology centers to community clinics, neonatal units, mobile health programs, and other underserved settings.

Through innovation, clinical collaboration, and scalable technology, we aim to reduce barriers to retinal imaging, support healthcare professionals in making timely and informed decisions, and improve eye health outcomes worldwide.

Collaboration

Built across disciplines.

Our work brings together industry, engineering, and clinical medicine through three collaborating partners.

BioLight Engineering LLC

The company translating federally funded optical research into portable, non-mydriatic imaging devices.

UIC Biomedical Engineering

The Department of Biomedical Engineering at the University of Illinois Chicago, driving device design and engineering.

UIC College of Medicine

Clinical partners in ophthalmology guiding real-world validation and pediatric application.

Leadership

Our team.

BioLight Engineering brings together leaders in optical engineering, ophthalmic imaging, and clinical medicine.

Dr. Youbo Zhao

Youbo Zhao, PhD

Chief Executive Officer

Dr. Zhao brings extensive experience in optical instrumentation, technology innovation, research leadership, and technology commercialization. Before joining BioLight Engineering LLC, he served as a Group Leader at Physical Sciences Inc. (PSI), where he led multidisciplinary R&D programs spanning advanced optical imaging, sensing technologies, and biomedical instrumentation. Over the past decade, he has secured and managed more than $15 million in funding from NIH, DOE, DARPA, ARPA-H, and internal corporate sources.

His expertise includes optical system design, high-speed imaging, fluorescence microscopy, computational imaging, electronics integration, and the management of multidisciplinary engineering teams.

As CEO, Dr. Zhao provides strategic leadership for BioLight Engineering's business growth, technology commercialization, product development, clinical validation, regulatory strategy, partnerships, and fundraising.

Dr. Xincheng Yao

Xincheng Yao, PhD, FAIMBE, FSPIE, FOptica

Founder & Chief Technology Officer

Dr. Xincheng Yao is the Founder and Chief Technology Officer of BioLight Engineering LLC and an internationally recognized pioneer in ophthalmic imaging technologies. He serves as the Richard & Loan Hill Endowed Chair and Professor of Biomedical Engineering and Ophthalmology & Visual Sciences at the University of Illinois Chicago (UIC).

Dr. Yao's expertise spans biomedical optics, computational imaging, ophthalmic instrumentation, and translational medical device development. He has authored numerous scientific publications, holds multiple patents, and has mentored multidisciplinary teams of engineers, scientists, and clinicians.

As Founder and CTO, Dr. Yao provides the technological vision for BioLight Engineering and leads the company's innovation strategy, translating cutting-edge research into practical, affordable retinal imaging solutions.

Dr. TaeYun Son

TaeYun Son, PhD

Principal Scientist

Dr. TaeYun Son is a biomedical engineer specializing in the development and translation of innovative ophthalmic imaging technologies into clinically practical medical devices. His expertise spans optical instrumentation, retinal imaging, computational imaging, and biomedical optics.

As the leading Principal Investigator of BioLight Engineering's NIH SBIR program, Dr. Son leads the scientific and technical execution of the company's flagship retinal imaging projects, working in close partnership with the Multi-Principal Investigators at the University of Illinois Chicago.

He works closely with engineers, clinicians, and regulatory partners to ensure BioLight's technologies address real-world clinical needs while maintaining high standards of performance, usability, and affordability.

Dr. Alfa Rossi

Alfa Rossi, PhD

Project Manager

Dr. Alfa Rossi received his PhD in Biomedical Engineering from the University of Illinois Chicago, where his doctoral research focused on developing affordable ultra-widefield fundus imaging systems for pediatric and adult retinal examinations. He has played a leading role in developing multiple portable retinal imaging systems, including the company's flagship PedCam platform.

His expertise includes optical system design, optomechanical engineering, imaging software integration, and translational medical device development. He has authored numerous peer-reviewed publications and is a co-inventor on patent applications related to retinal imaging technologies.

As Project Manager, Dr. Rossi coordinates technology development across multidisciplinary teams, helping transform innovative concepts into practical ophthalmic imaging products.

Dr. Robison V. Paul Chan

Robison V. Paul Chan, MD, MSc, MBA, FACS

Clinical Advisor

Dr. Robison V. Paul Chan is the John H. Panton Professor and Chair of the Department of Ophthalmology and Visual Sciences at the University of Illinois Chicago and an internationally recognized pediatric retina specialist. His career has focused on retinopathy of prematurity (ROP), pediatric retinal diseases, telemedicine, and global eye health.

Dr. Chan serves as a Multi-Principal Investigator on BioLight Engineering's NIH SBIR PedCam projects, leading the clinical translation and validation of the company's technologies through a long-standing collaboration between BioLight Engineering and the University of Illinois Chicago.

Dr. Devrim Toslak

Devrim Toslak, MD

Clinical Advisor

Dr. Devrim Toslak is an Associate Professor of Ophthalmology at Antalya Training and Research Hospital, Türkiye. He was a visiting scholar in Dr. Xincheng Yao's Biomedical Optics and Ophthalmic Imaging Laboratory at the University of Illinois Chicago from 2015 to 2020, where he played a key role in developing innovative retinal imaging technologies.

He is a co-inventor of BioLight Engineering's foundational PedCam technology based on trans-pars-planar illumination. As Clinical Advisor, he provides clinical insights that guide technology development, clinical validation, and the global translation of BioLight's retinal imaging solutions.

Get in touch

Contact us

For inquiries about our development program, research collaboration, or federal funding record, please reach out.